Jump to content
Wikipedia The Free Encyclopedia

Lundbeck Seattle Biopharmaceuticals

From Wikipedia, the free encyclopedia
This is the current revision of this page, as edited by Citation bot (talk | contribs) at 22:06, 26 September 2023 (Removed parameters. | Use this bot. Report bugs. | #UCB_CommandLine). The present address (URL) is a permanent link to this version.Revision as of 22:06, 26 September 2023 by Citation bot (talk | contribs) (Removed parameters. | Use this bot. Report bugs. | #UCB_CommandLine)
(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)
Pharmaceutical development company
Lundbeck Seattle Biopharmaceuticals
FormerlyAlder Biopharmaceuticals
Company typeSubsidiary
Founded1 January 2004
2004 Edit this on Wikidata
Headquarters,
U.S.
Parent Lundbeck
Websitehttps://www.lundbeck.com/us/about-us/lundbeck-in-the-us

Lundbeck Seattle Biopharmaceuticals is a pharmaceutical development company based in Bothell, Washington. Formerly known as Alder Biopharmaceuticals, it specializes in therapeutic monoclonal antibodies.

In May 2014, Alder went public.[1] In early 2018, the company made a public stock offering, aiming to raise US250ドル million.[2] The company identifies, develops, and manufactures antibody therapeutics to alleviate human suffering in cancer, pain, cardiovascular, and autoimmune and inflammatory disease areas.[3]

As of September 2019, the Alder Biopharmaceuticals shares have increased with 83% in price, following the company's acquisition by the Denmark-based H. Lundbeck, in a deal valued at 1ドル.95 billion.[4] [5] The company subsequently changed its name to Lundbeck Seattle Biopharmaceuticals after the acquisition.[6]

References

[edit ]
  1. ^ "Alder BioPharmaceuticals stock flat after unexciting IPO". geekwire.com. 8 May 2014. Retrieved 24 August 2017.
  2. ^ "Deals this week: Onconova Therapeutics, Humorigin Biotechnology, Zosano Pharma". Drug Development Technology. Kable. 2 February 2018. Retrieved 3 February 2018.
  3. ^ "Alder Biopharmaceuticals Inc - Company Profile and News". Bloomberg.com. Retrieved 2019年05月21日.
  4. ^ Kilgore, Tomi (2019年09月16日). "Alder BioPharmaceuticals stock rockets on heavy volume after 1ドル.95 billion buyout deal". Market Watch. Retrieved 2019年10月21日.
  5. ^ staff, Seattle Times business (2019年09月16日). "Alder BioPharma, Bothell developer of migraine-prevention drug, acquired for up to 2ドル billion". The Seattle Times. Retrieved 2020年06月18日. {{cite web}}: |first= has generic name (help)
  6. ^ Podsada, Janice (August 5, 2020). "Bay Area bio-tech firm to open production plant in Bothell". The Everett Herald . Retrieved February 19, 2022.
Stub icon

This article about a medical, pharmaceutical or biotechnological corporation or company is a stub. You can help Wikipedia by expanding it.

AltStyle によって変換されたページ (->オリジナル) /